An observational study in Functional Gastrointestinal Disorders, sponsored by Zhejiang University. Status unknown. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2020-05-14.
Sponsored by Zhejiang University · Observational
This study plans to understand the prevalence and clinical characteristics of pediatric functional gastrointestinal disorders in mainland China through multi-center investigation and clinical epidemiological analysis, to reveal the prevalence characteristics and related factors of functional gastrointestinal disorders in children of all ages in mainland China, to establish a diagnostic standard system for pediatric functional gastrointestinal disorders in mainland China, to provide evidence-based basis for the formulation of new Roman standard for functional gastrointestinal disorders, and to provide new ideas and treatment basis for the diagnosis and treatment of functional gastrointestinal disorders in children.
Functional gastrointestinal disorders (FGIDs), also known as brain-intestinal interaction abnormalities, are associated with dynamic disorders, high visceral sensitivity, changes in mucosal and immune functions, changes in intestinal flora, and abnormal central nervous system regulatory functions. FGIDs are the most common causes of diagnosis and treatment of gastrointestinal diseases in children. During the past 10 years, new progress has been made in the study of various FGIDs in children of different ages. FGIDs Rome Commission of Experts revised the relevant diagnostic criteria and officially published the Rome IV criteria for pediatric FGIDs in Gastroenterology in 2016. Due to many factors, the epidemiological survey data of pediatric FGID are still lacking in China. Whether Rome II, Rome III or Rome IV, their diagnostic criteria and epidemiological data were from other countries and regions, so their suitability for China's children remains to be verified. This study plans to understand the prevalence and clinical characteristics of pediatric functional gastrointestinal disorders in mainland China through multi-center investigation and clinical epidemiological analysis, to reveal the prevalence characteristics and related factors of functional gastrointestinal disorders in children of all ages in mainland China, to establish a diagnostic standard system for pediatric functional gastrointestinal disorders in mainland China, to provide evidence-based basis for the formulation of new Roman standard for functional gastrointestinal disorders, and to provide new ideas and treatment basis for the diagnosis and treatment of pediatric functional gastrointestinal disorders.
628 studies on the registry are indexed under Gastrointestinal Diseases; 128 are open to participants now.
This study's planned enrollment of 1,500 is above the median of 325 across 190 observational studies indexed under Gastrointestinal Diseases.
Browse Gastrointestinal Diseases studies →Zhejiang University is the lead sponsor of 351 studies on the registry; 165 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children who visit the gastroenterology department due to gastrointestinal symptoms
Exclusion Criteria:
No intervention.
Other: No intervention.
No intervention.
Other: No intervention.
No intervention.
the prevalence rate
the prevalence rate of pediatric functional gastrointestinal disorders in mainland China
Time frame: From date of finishing the disease diagnosis until the date of statistical analysis completed, assessed up to 6 months
the Rome IV questionnaire
to understand the clinical characteristics of pediatric functional gastrointestinal disorders in mainland China
Time frame: From date of finishing the questionnaire until the date of statistical information completed, assessed up to 3 months
No study locations are listed for this record.
Plan to share: No
This study is status unknown, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zhejiang University